The highest risk for poor outcome and survival was found in Schell Class 4 cancers (two or more truncating APC mutations plus mutations in TP53 and KRAS), followed by Schell Class 0 (no truncating APC mutations) [4]. The gene discussed is KRAS; the disease is cancer.